Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481530 · ClinicalTrials.gov registry record
Role of CGMS Usage in Predicting Risk for Hypoglycemia
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 41
- Enrollment target
NCT03481530 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 41 participants.
The verdict
NCT03481530 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
This is a clinical study to examine rates hypoglycemia (self-report, EHR review, and review of values from a FDA approved continuous glucose monitoring system (CGMS)). Subjects will wear either blinded or unblinded CGMS. This is a 1:1 assignment with one group (50%) wearing 1 unblinded/1 blinded CGMS and the other group 50% wearing 2 blinded CGMS. The assignment will be computer based in a random fashion. Participants will continue with their usual diabetes management and glycemic monitoring profile as per usual. Those assigned to an unblinded CGMS can use the CGMS to manage their glucose levels at their own discretion. Individuals recruited will be those Type 2 diabetes who are deemed to be at high risk for hypoglycemia or low risk for hypoglycemia from a point score system established in an affiliated study.
Interventions
- DEVICE Continuing Glucose Monitor System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2025-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03481530
The ClinicalTrials.gov registry entry for NCT03481530 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuing Glucose Monitor System is the first listed.
NCT03481530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03481530 about?
NCT03481530 is a clinical study titled "Role of CGMS Usage in Predicting Risk for Hypoglycemia". This is a clinical study to examine rates hypoglycemia (self-report, EHR review, and review of values from a FDA approved continuous glucose monitoring system (CGMS)). Subjects will wear either blinded or unblinded CGMS. This is a 1:1 assignment with one group (50%) wearing 1 unblinded/1 blinded CGM...
What is the current status of trial NCT03481530?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2018-10-01. Estimated completion is 2025-09-30.
What interventions are being tested in trial NCT03481530?
The interventions under investigation include: Continuing Glucose Monitor System (DEVICE).
Who is sponsoring clinical trial NCT03481530?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.